demonstrated that high-dose AA inhibited PD-L1 expression in breast cancer cell lines, enhanced antitumor effects of T cells, and inhibited PD-L1 transcription through the ROS-phosphorylated signal transducer and activator of transcription 3 (pSTAT3) signaling pathway (16). This evidence concerns the gene CD274 and breast carcinoma.